Elena Ridloff Insider Trading $ACAD ACADIA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Elena Ridloff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elena Ridloff. Elena Ridloff is EVP and CFO in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in Kronos Bio, Inc. ($KRON) and Director in Kymera Therapeutics, Inc. ($KYMR).
Elena Ridloff in ACADIA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elena Ridloff: EVP and CFO
Holdings: 11,585 shares
Current Value: $442,431
Latest Transaction: Apr 30 2021
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Elena Ridloff in ACADIA PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, KRON, KYMR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 0.00 | 3,245 | 0 | 6,491 | |
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 20.33 | 1,032 | 20,981 | 10,553 | 11.6 K to 10.6 K (-8.91 %) |
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 0.00 | 3,245 | 0 | 11,585 | 8.3 K to 11.6 K (+38.91 %) |
| Feb 25 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 0.00 | 9,839 | 0 | 9,839 | |
| Feb 25 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 49.74 | 36,231 | 1,802,130 | 36,231 | |
| Feb 08 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 50.61 | 2,051 | 103,801 | 8,340 | 10.4 K to 8.3 K (-19.74 %) |
| Feb 08 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Grant | A | 0.00 | 6,490 | 0 | 10,391 | 3.9 K to 10.4 K (+166.37 %) |
| Jan 08 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 0.00 | 1,016 | 0 | 9,873 | |
| Jan 08 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 53.34 | 1,016 | 54,193 | 3,901 | 4.9 K to 3.9 K (-20.66 %) |
| Jan 08 2021 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 0.00 | 2,722 | 0 | 4,917 | 2.2 K to 4.9 K (+124.01 %) |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 0.00 | 3,245 | 0 | 9,736 | |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 25.12 | 10,000 | 251,200 | 35,547 | |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 49.22 | 1,050 | 51,681 | 2,195 | 3.2 K to 2.2 K (-32.36 %) |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 0.00 | 3,245 | 0 | 3,245 | 0 to 3.2 K |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 50.74 | 10,000 | 507,353 | 0 | 10 K to 0 (-100.00 %) |
| May 01 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 25.12 | 10,000 | 251,200 | 10,000 | 0 to 10 K |
| Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 0.00 | 10,889 | 0 | 10,889 | |
| Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 42.81 | 39,516 | 1,691,680 | 39,516 | |
| Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 15.81 | 36,000 | 569,160 | 64,000 | |
| Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 49.09 | 19,478 | 956,253 | 0 | 19.5 K to 0 (-100.00 %) |
| Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 49.81 | 5,502 | 274,044 | 19,478 | 25 K to 19.5 K (-22.03 %) |
| Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 50.60 | 11,020 | 557,557 | 24,980 | 36 K to 25 K (-30.61 %) |
| Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 15.81 | 36,000 | 569,160 | 36,000 | 0 to 36 K |
| May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 0.00 | 12,981 | 0 | 12,981 | |
| May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 25.12 | 45,547 | 1,144,141 | 45,547 |
Page: 1